JNJ-7777120 je lek koji je razvila kompanija Džonson & Džonson. On deluje kao potentan i selektivan antagonist histaminskog H4 receptora.[1] On ima antiinflamatorno dejstvo.[2] Pokazano je da je superioran u odnosu na traditionalne antihistamine u treatmanu pruritusa (svraba).[3]

JNJ 7777120
IUPAC ime
5-hloro-2-[(4-metilpiperazin-1-il)karbonil]-1H-indol
Identifikatori
CAS broj459168-41-3 ДаY
ATC kodnone
PubChemCID 4908365
IUPHAR/BPS1278
ChEMBLCHEMBL129198 ДаY
Sinonimi1-[(5-hloro-1H-indol-2-il)karbonil]-4-metilpiperazin
Hemijski podaci
FormulaC14H16ClN3O
Molarna masa277,749 g/mol
  • C3CN(C)CCN3C(=O)c(cc1c2)nc1ccc2Cl

Reference

уреди
  1. ^ Jiang W; Lim, HD; Zhang M; et al. (2008). „Cloning and pharmacological characterization of the dog histamine H(4) receptor”. Eur. J. Pharmacol. 592 (1–3): 26—32. PMID 18639542. doi:10.1016/j.ejphar.2008.06.095. 
  2. ^ Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L. Thurmond, R. L.; Desai, P. J.; Dunford, P. J.; Fung-Leung, W. P.; Hofstra, C. L.; Jiang, W.; Nguyen, S.; Riley, J. P.; Sun, S.; Williams, K. N.; Edwards, J. P.; Karlsson, L. (април 2004). „A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties”. Journal of Pharmacology and Experimental Therapeutics. 309 (1): 404—13. PMID 14722321. doi:10.1124/jpet.103.061754. 
  3. ^ Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL. Dunford, P. J.; Williams, K. N.; Desai, P. J.; Karlsson, L.; McQueen, D.; Thurmond, R. L. (јануар 2007). „Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus”. Journal of Allergy and Clinical Immunology. 119 (1): 176—83. PMID 17208599. doi:10.1016/j.jaci.2006.08.034. 

Spoljašnje veze

уреди